| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/07/2006 | US20060198902 Topical medicament and method of use |
| 09/07/2006 | US20060198899 Supplemental dietary composition for supporting muscle growth, recovery and strength |
| 09/07/2006 | US20060198898 Orally administering edible oil homogenized with an edible wax at a concentration ranging from 0.5% to 50% by weight and a sterol compound at a concentration of at least 0.1% by weight for repairing and promoting regeneration of mucosa in the GI tract |
| 09/07/2006 | US20060198896 Aerosol and injectable formulations of nanoparticulate benzodiazepine |
| 09/07/2006 | US20060198895 Azithromycin powder for oral suspension compositions |
| 09/07/2006 | US20060198893 Aqueous dispersion comprising stable nanoparticles of a water-insoluble pyrrole carboxamide and excipient like middle chain triglycerides |
| 09/07/2006 | US20060198888 Tolperisone-containing pharmaceutical preparation with controllable active-substance release for oral administration |
| 09/07/2006 | US20060198887 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
| 09/07/2006 | US20060198886 Medicament having coated methenamine combined with acidifier |
| 09/07/2006 | US20060198885 Oral pharmaceutical composition |
| 09/07/2006 | US20060198884 Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane |
| 09/07/2006 | US20060198883 Compositions and methods for the treatment of anorectal disorders |
| 09/07/2006 | US20060198882 Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer |
| 09/07/2006 | US20060198881 Tamper resistant transdermal dosage form |
| 09/07/2006 | US20060198880 Ultraviolet-shielding type patch |
| 09/07/2006 | US20060198873 Orally dissolving films |
| 09/07/2006 | US20060198871 Methods for treating neovascularization and intravitreal implants |
| 09/07/2006 | US20060198870 Medical devices containing rapamycin analogs |
| 09/07/2006 | US20060198867 Compositions and methods of administering rapamycin analogs using medical devices for long-term efficacy |
| 09/07/2006 | US20060198863 Formable composition; tricalcium phosphate particles in hydrogel carrier; aqueous solution contqining citric acid buffer; controlling particle size |
| 09/07/2006 | US20060198856 Ibuprofen suspension stabilized with docusate sodium |
| 09/07/2006 | US20060198850 Pharmaceutical formulation and a method of making same |
| 09/07/2006 | US20060198846 Combinations for the treatment of diseases involving angiogenesis |
| 09/07/2006 | US20060198843 a cancer which expresses epidermal growth factor receptor; blocking ligand activation of a receptor; binding of monoclonal antibody 2C4 to ErbB2; chemotherapeutic agents are 5-fluorouracil leucovorin, levamisole |
| 09/07/2006 | US20060198836 Method of treating hit patients with argatroban |
| 09/07/2006 | US20060198830 Ubiquinone composition and a container for its convenient transport and storage |
| 09/07/2006 | US20060198824 Treatments for flaviviridae virus infection |
| 09/07/2006 | US20060198821 administering to said individual an effective amount of either i) recombinant protein CD73 or ii) a cytokine or another factor-being capable of inducing endothelial CD73 expression; inflammation |
| 09/07/2006 | US20060198820 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
| 09/07/2006 | US20060198818 Method for analyzing activated polyethylene glycol compounds |
| 09/07/2006 | US20060198817 Materials and methods for preventing and treating microbe-mediated epithelial disorders |
| 09/07/2006 | US20060198816 In situ bulking composition |
| 09/07/2006 | US20060198815 Pharmaceutical formulations for sustained release |
| 09/07/2006 | US20060198814 Preventing the intrusion of microorganisms into body cavities or body openings of mammals comprising of a poly(N-vinyl lactam), a polysaccharide and water; stable in a wide temperature range |
| 09/07/2006 | US20060198813 Substituted fullerene compositions and their use in treatment of shock |
| 09/07/2006 | US20060198810 Plant based formulations for improving skin moisture, texture, and appearance |
| 09/07/2006 | US20060198800 Skin care compositions including hexapeptide complexes and methods of their manufacture |
| 09/07/2006 | US20060198790 Buccal, polar and non-polar spray containing ondansetron |
| 09/07/2006 | US20060196500 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage |
| 09/07/2006 | DE19526233B4 Hydroxylierte Azabicyclooctyl-tetra- und -hexahydrobenz[d,e]isochinolone, deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten Hydroxylated Azabicyclooctyl tetra- and -hexahydrobenz [e] isochinolone, their preparation and pharmaceutical compositions containing these |
| 09/07/2006 | DE10255343B4 N,N-Verbrückte, Stickstoff-Substituierte Carbacyclische Indolocarbazole als Proteinkinase-Inhibitoren N, N-bridged, nitrogen-substituted carbacyclic indolocarbazoles as protein kinase inhibitors |
| 09/07/2006 | DE102006007309A1 Preparing temozolomide base, useful as antitumor agent, comprises preparing temozolomide hydrochloride and converting to temozolomide base in acidic medium |
| 09/07/2006 | DE102006006123A1 Use of alk-2-en-4-acidamide compounds e.g. as aroma materials, for producing tingling sensation or cooling effect and/or stimulation of saliva in mouth, for mouth hygiene and in oral pharmaceutical preparation |
| 09/07/2006 | DE102005010000A1 Indane Indanes |
| 09/07/2006 | DE102005009990A1 Salze, Anlagerungs- und Komplexverbindungen der Guanidinoessigsäure Salts, annealing and complex compounds of guanidinoacetic |
| 09/07/2006 | DE102005009909A1 Verbindungen geeignet zur Beseitigung fehlgefalteter Proteine Compounds suitable for the removal of misfolded proteins |
| 09/07/2006 | DE102005009705A1 Use of naphthalene derivatives for the treatment of hyperaldosteronism, heart failure, myocardial fibrosis, hypercortisolism and diabetes mellitus |
| 09/07/2006 | DE102005009515A1 Verfahren zur Herstellung einer Zubereitung einer DMSO-haltigen festen Silikonölemulsion zur Bindung von reaktiven Sauerstoffverbindungen im Körper von Menschen und Tieren A process for the preparation of a composition of a DMSO-containing solid silicone oil emulsion for binding of reactive oxygen species in the body of humans and animals |
| 09/07/2006 | DE102005009440A1 Thienopyridinderivate Thienopyridine derivatives |
| 09/07/2006 | DE102005009379A1 Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung Compositions comprising folic acid, vitamin B6 and vitamin B12, and its use |
| 09/07/2006 | DE102005009241A1 Arzneiformen mit kontrollierter Bioverfügbarkeit Dosage forms with controlled bioavailability |
| 09/07/2006 | DE102005009240A1 Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften Dosage forms with improved pharmacokinetic properties |
| 09/07/2006 | DE102005008797A1 Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung Trofosfamide-containing film-coated tablets and to processes for their preparation |
| 09/07/2006 | DE102005008649A1 Neue substituierte Pyrrolidinone, deren Herstellung und deren Verwendung als Arzneimittel New substituted pyrrolidinones, their preparation and their use as medicaments |
| 09/07/2006 | DE102005008412A1 New piperazine salt of omeprazol is proton pump inhibitor useful to prevent/treat e.g. peptic ulcer, gastritis, gastroesophageal reflux, acute stress ulcer or dyspepsia |
| 09/07/2006 | DE10038043B4 Phamakologisch wirksame Substanz zur Behandlung kardiovaskulärer Erkrankungen Of pharmacologically active substance for the treatment of cardiovascular diseases |
| 09/06/2006 | EP1698697A2 SSD-containing protein, process for producing the same and use thereof |
| 09/06/2006 | EP1698696A1 Target protein of antidiabetic agent and novel antidiabetic agent insuful corresponding thereto |
| 09/06/2006 | EP1698695A2 Antisense oligonucleotides for the inhibition of expression of type I procollagen |
| 09/06/2006 | EP1698685A1 Fat composition |
| 09/06/2006 | EP1698635A1 Benzimidazole derivatives and medical uses thereof |
| 09/06/2006 | EP1698630A1 New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations |
| 09/06/2006 | EP1698629A2 Polyamines and their use in therapy |
| 09/06/2006 | EP1698628A1 Hydroxypyrimidinone derivative having hiv integrase inhibitory activity |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1698626A1 Amidopyrazole derivative |
| 09/06/2006 | EP1698624A1 Phenylpropanoic acid derivatives |
| 09/06/2006 | EP1698623A1 Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 09/06/2006 | EP1698622A1 Agent or method for treatment for severe aphasia in chronic-stage cerebrovascular disorder |
| 09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 09/06/2006 | EP1698375A1 Azetidine ring compounds and drugs comprising the same |
| 09/06/2006 | EP1698351A2 Glycopeptide compositions |
| 09/06/2006 | EP1698348A1 Remedy/preventive for vascular disorders and hypertension and method of screening the same |
| 09/06/2006 | EP1698344A1 Dietary supplement with piperin |
| 09/06/2006 | EP1698342A1 Use of carbohydrates for eliminating intestinal infections in animals |
| 09/06/2006 | EP1698341A2 Use of carbohydrates for eliminating intestinal infections in animals |
| 09/06/2006 | EP1698340A1 T-type calcium channel inhibitor |
| 09/06/2006 | EP1698339A1 Neutrophilia inhibitor |
| 09/06/2006 | EP1698338A2 S-methyl-dihydro-ziprasidone for the treatment of schizophrenia |
| 09/06/2006 | EP1698337A1 Use of cyclic amine derivatives in capillary products |
| 09/06/2006 | EP1698336A1 Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent |
| 09/06/2006 | EP1698335A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates |
| 09/06/2006 | EP1698334A1 Pharmaceutically active isoindoline derivatives |
| 09/06/2006 | EP1698333A1 Fulvic acid and its use in the treatment of viral infections |
| 09/06/2006 | EP1698332A1 Oral modified release formulations containing 8-Prenylnaringenin for continuous estrogen support |
| 09/06/2006 | EP1698330A1 Anti-inflammatory analgesic external preparation |
| 09/06/2006 | EP1698329A1 Drug-containing nanoparticle, process for producing the same and parenterally administered preparation from the nanoparticle |
| 09/06/2006 | EP1698328A2 Concentrate of Tocopherol |
| 09/06/2006 | EP1698327A1 Stable pharmaceutical compositions of itraconazole in aqueous environment |
| 09/06/2006 | EP1698325A1 Compositions containing amines and use thereof |
| 09/06/2006 | EP1697544A2 Genes commonly regulated by different classes of antidepressants |
| 09/06/2006 | EP1697536A2 Novel oligonucleotides and treating cardiac disorders by using the same |
| 09/06/2006 | EP1697499A2 Methods of treating cardiac disorders by suppressing the expression of the potassium inwardly-rectifying channel |
| 09/06/2006 | EP1697498A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 09/06/2006 | EP1697481A2 Bioadhesive polymers with catechol functionality |
| 09/06/2006 | EP1697397A1 Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation |
| 09/06/2006 | EP1697394A2 Comt inhibitors |
| 09/06/2006 | EP1697392A1 Glycosylated triketide delta lactones |
| 09/06/2006 | EP1697389A2 Compounds and methods for treating toll-like receptor 2-related diseases and conditions |
| 09/06/2006 | EP1697384A1 Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |